Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 608-615

  Kalenikova, E I ^a,c   Gorodetskaya, E A ^a   Zacharova, N V ^a   Shechter, A B ^b   Medvedev, O S ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

ACE inhibitors; Angiotensins; Cardioprotection; Coronary microembolization; Lung clearance

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINE 125; MICROSPHERE; PENTOBARBITAL; PERINDOPRIL;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; DRUG SCREENING; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LUNG CIRCULATION; MALE; MICROEMBOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEADY STATE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMODYNAMIC PROCESSES; INDOLES; INFUSIONS, INTRAVENOUS; LUNG; MALE; MICROSPHERES; PERINDOPRIL; RATS; RATS, WISTAR;

EID: 0031680642     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00013     Document Type: Article

References (30)

1. Andersson B. Waagstein F. Spectrum and outcome of congestive heart failure in hospitalized population. Am Heart J 1993;126:632-40.
2. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991;121:1852-3.
3. Pouleur H, Benedict CR, Rousseau MF. Neurohormones in patients with ischemic left ventricular dysfunction. Cardiovasc Drugs Ther 1994;8:313-7.
4. Coats AJS, Adamopoulos S. Neurohormonal mechanisms and role of angiotensin-converting enzyme (ACE) inhibitors in heart failure. Cardiovasc Drugs Ther 1994;8:685-92.
5. Teerlink JR. Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system. J Cardiovasc Pharmacol 1996;27(suppl 2):S1-8.
6. van Zwieten PA. Current and newer approaches in the drug treatment of congestive heart failure. Cardiovasc Drugs Ther 1996;10:693-702.
7. Clealand JGF. The renin-angiotensin system in the heart failure. Herz. 1990;16:68-81.
8. Mareev VY. Treatment of heart failure - inotropic stimulation or load reduction. Kardiologiya 1995;35(12):4-12 (in Russian).
9. Gorodetskaya EA, Dugin SF, Medvedev OS, Allabergenova EA. Simple method to produce acute heart failure by coronary vessel embolization in closed chest rats with microspheres. J Pharmacol Methods 1990;24:43-51.
10. Medvedev OS, Gorodetskaya EA. Systemic and regional hemodynamic effects of perindopril in experimental heart failure. Am Heart J 1993;126:764-9.
11. 131I labeled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-23.
12. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H. Schalekamp ADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:44-55.
13. Bennett HPJ, Hudson A, Kelly L, McMartin C, Purdon GE. A rapid method, using octadecasilyl-silica, for the extraction of certain peptides from tissues. Biochem J 1978;175:1139-41.
14. Admiraal PJJ, Danser AHJ, Jong MS, Pieterman H, Derkx FHM, Schalekamp ADH. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993;21:173-84.
15. Danser AHJ, Koning MM, Admiraal PJJ, Derkx FHM, Verdouw PD, Schalekamp MADH. Production of angiotensins I and II in the intact pig. Am J Physiol 1992;263:H429-37.
16. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991;18:763-73.
17. Wollert KC, Studer R, Bulow B, Drexler H. Survival after myocardial infarction in the rat: role of tissue angiotensin-converting enzyme inhibition. Circulation 1994;90:2457-67.
18. Huang H, Arnal J-F, Llorens-Cortes C, et al. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure: a novel aspect of endothelium dysfunction. Circ Res 1994;75:454-61.
19. Helin K, Tikkanen I, Hohenthal U, Fyhrquist F. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes. Eur J Pharmacol 1994;264:135-41.
20. Shunkert H, Indelfinger JR, Hirch AT, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-8.
21. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H. Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982;4:966-72.
22. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-90.
23. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994;23:439-49.
24. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin convening enzyme in experimental heart failure. Circ Res 1991;69:475-82.
25. Smits JF, Passier RC, Nelissen-Vrancken HJ, Cleutjens JP, Kuizinga MC, Daemen MJ. Does ACE inhibition limit structural changes in the heart following myocardial infarction? Eur Heart J 1995;16(suppl N):46-51.
26. Goldstein S, Sabbah H. Ventricular remodeling and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994;24(suppl 3):S27-31.
27. Goldstein S, Sharov VG, Cook JM, Sabbah HN. Ventricular remodelling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors. Mol Cell Biochem 1995;147:51-5.
28. Sanbe A, Tanonaka K, Kobayasi R, Takeo S. Effects of long term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Moll Cell Cardiol 1995;27:2209-22.
29. Weber MA, Neutel JM, Smith DHG. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. Am Heart J 1992;123:1414-20.
30. Campbell DJ, Kladis A, Duncan A-M. Bradykinin peptides in kidney, blood, and other tissues of rat. Hypertension 1993;21:155-65.